{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:47:00Z","timestamp":1788526020255,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11060-026-05656-7","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:42:24Z","timestamp":1780749744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic impact of concomitant leptomeningeal disease in breast cancer patients with brain metastases: a large single-center cohort study"],"prefix":"10.1007","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1908-778X","authenticated-orcid":false,"given":"Romina D.","family":"Ben\u00edtez-Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4320-9448","authenticated-orcid":false,"given":"Paula","family":"Cabrera-Galeana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1519-3613","authenticated-orcid":false,"given":"Juan A.","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5065-7922","authenticated-orcid":false,"given":"Yolanda","family":"Villase\u00f1or-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1164-3779","authenticated-orcid":false,"given":"Oscar","family":"Arrieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2973-035X","authenticated-orcid":false,"given":"Jos\u00e9 Omar","family":"Navarro-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7916-1629","authenticated-orcid":false,"given":"Orwa","family":"Aboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8916-6258","authenticated-orcid":false,"given":"Alberto","family":"Gonz\u00e1lez-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9289-5312","authenticated-orcid":false,"given":"Bernardo","family":"Cacho-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"8","key":"5656_CR1","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/jamaoncol.2017.0001","volume":"3","author":"AM Martin","year":"2017","unstructured":"Martin AM, Cagney DN, Catalano PJ et al (2017) Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study. JAMA Oncol 3(8):1069\u20131077. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0001","journal-title":"JAMA Oncol"},{"issue":"24","key":"5656_CR2","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1200\/JCO.20.02822","volume":"39","author":"NU Lin","year":"2021","unstructured":"Lin NU, Pegram M, Sahebjam S et al (2021) Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study. J Clin Oncol Off J Am Soc Clin Oncol 39(24):2667\u20132675. https:\/\/doi.org\/10.1200\/JCO.20.02822","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"5656_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","volume":"5","author":"AS Achrol","year":"2019","unstructured":"Achrol AS, Rennert RC, Anders C et al (2019) Brain metastases. Nat Rev Dis Primer 5(1):5. https:\/\/doi.org\/10.1038\/s41572-018-0055-y","journal-title":"Nat Rev Dis Primer"},{"issue":"7","key":"5656_CR4","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jamaoncol.2018.0813","volume":"4","author":"DN Cagney","year":"2018","unstructured":"Cagney DN, Martin AM, Catalano PJ et al (2018) Implications of Screening for Brain Metastases in Patients With Breast Cancer and Non-Small Cell Lung Cancer. JAMA Oncol 4(7):1001\u20131003. https:\/\/doi.org\/10.1001\/jamaoncol.2018.0813","journal-title":"JAMA Oncol"},{"issue":"1","key":"5656_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00109-013-1108-z","volume":"92","author":"DH Murrell","year":"2014","unstructured":"Murrell DH, Foster PJ, Chambers AF (2014) Brain metastases from breast cancer: lessons from experimental magnetic resonance imaging studies and clinical implications. J Mol Med 92(1):5\u201312. https:\/\/doi.org\/10.1007\/s00109-013-1108-z","journal-title":"J Mol Med"},{"issue":"3","key":"5656_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1470-2045(13)70017-2","volume":"14","author":"BC Pestalozzi","year":"2013","unstructured":"Pestalozzi BC, Holmes E, de Azambuja E et al (2013) CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1\u201301). Lancet Oncol 14(3):244\u2013248. https:\/\/doi.org\/10.1016\/S1470-2045(13)70017-2","journal-title":"Lancet Oncol"},{"issue":"22","key":"5656_CR7","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1002\/cncr.27581","volume":"118","author":"NU Lin","year":"2012","unstructured":"Lin NU, Vanderplas A, Hughes ME et al (2012) Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer 118(22):5463\u20135472. https:\/\/doi.org\/10.1002\/cncr.27581","journal-title":"Cancer"},{"issue":"2","key":"5656_CR8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ijrobp.2020.01.051","volume":"107","author":"PW Sperduto","year":"2020","unstructured":"Sperduto PW, Mesko S, Li J et al (2020) Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today. Int J Radiat Oncol 107(2):334\u2013343. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.01.051","journal-title":"Int J Radiat Oncol"},{"key":"5656_CR9","doi-asserted-by":"publisher","first-page":"102448","DOI":"10.1016\/j.canep.2023.102448","volume":"86","author":"B Cacho-D\u00edaz","year":"2023","unstructured":"Cacho-D\u00edaz B, Meneses-Garc\u00eda AA, Vald\u00e9s-Ferrer SI, Reynoso-Nover\u00f3n N (2023) A brain metastasis prediction model in women with breast cancer. Cancer Epidemiol 86:102448. https:\/\/doi.org\/10.1016\/j.canep.2023.102448","journal-title":"Cancer Epidemiol"},{"issue":"5","key":"5656_CR10","doi-asserted-by":"publisher","first-page":"101624","DOI":"10.1016\/j.esmoop.2023.101624","volume":"8","author":"E Le Rhun","year":"2023","unstructured":"Le Rhun E, Weller M, van den Bent M et al (2023) Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open 8(5):101624. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101624","journal-title":"ESMO Open"},{"issue":"31","key":"5656_CR11","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond MEH, Hicks DG et al (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol Off J Am Soc Clin Oncol 31(31):3997\u20134013. https:\/\/doi.org\/10.1200\/JCO.2013.50.9984","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"8","key":"5656_CR12","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Th\u00fcrlimann B, Senn HJ (2011) Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22(8):1736\u20131747. https:\/\/doi.org\/10.1093\/annonc\/mdr304","journal-title":"Ann Oncol"},{"issue":"7447","key":"5656_CR13","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/bmj.328.7447.1073","volume":"328","author":"JM Bland","year":"2004","unstructured":"Bland JM, Altman DG (2004) The logrank test. BMJ 328(7447):1073. https:\/\/doi.org\/10.1136\/bmj.328.7447.1073","journal-title":"BMJ"},{"issue":"12","key":"5656_CR14","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1093\/annonc\/mdn424","volume":"19","author":"R Largillier","year":"2008","unstructured":"Largillier R, Ferrero JM, Doyen J et al (2008) Prognostic factors in 1,038 women with metastatic breast cancer. Ann Oncol Off J Eur Soc Med Oncol 19(12):2012\u20132019. https:\/\/doi.org\/10.1093\/annonc\/mdn424","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"5656_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2018.07.004","volume":"102","author":"I Witzel","year":"2018","unstructured":"Witzel I, Laakmann E, Weide R et al (2018) Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry. Eur J Cancer 102:1\u20139. https:\/\/doi.org\/10.1016\/j.ejca.2018.07.004","journal-title":"Eur J Cancer"},{"issue":"3","key":"5656_CR16","doi-asserted-by":"publisher","first-page":"101213","DOI":"10.1016\/j.esmoop.2023.101213","volume":"8","author":"K Riecke","year":"2023","unstructured":"Riecke K, M\u00fcller V, Neunh\u00f6ffer T et al (2023) Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry. ESMO Open 8(3):101213. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101213","journal-title":"ESMO Open"},{"issue":"23","key":"5656_CR17","doi-asserted-by":"publisher","first-page":"6404","DOI":"10.1158\/1078-0432.CCR-13-0790","volume":"19","author":"NU Lin","year":"2013","unstructured":"Lin NU, Amiri-Kordestani L, Palmieri D, Liewehr DJ, Steeg PS (2013) CNS Metastases in Breast Cancer: Old Challenge, New Frontiers. Clin Cancer Res 19(23):6404\u20136418. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0790","journal-title":"Clin Cancer Res"},{"key":"5656_CR18","doi-asserted-by":"publisher","unstructured":"Le Rhun E, Weller M, van den Bent M et al (2023) Leptomeningeal metastasis from solid tumours: EANO\u2013ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open 8(5). https:\/\/doi.org\/10.1016\/j.esmoop.2023.101624","DOI":"10.1016\/j.esmoop.2023.101624"},{"issue":"5","key":"5656_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.21.02314","volume":"40","author":"MA Vogelbaum","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H et al (2022) Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. J Clin Oncol 40(5):492\u2013516. https:\/\/doi.org\/10.1200\/JCO.21.02314","journal-title":"J Clin Oncol"},{"issue":"10","key":"5656_CR20","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/neuonc\/noac118","volume":"24","author":"AA Aizer","year":"2022","unstructured":"Aizer AA, Lamba N, Ahluwalia MS et al (2022) Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions. Neuro-Oncol 24(10):1613\u20131646. https:\/\/doi.org\/10.1093\/neuonc\/noac118","journal-title":"Neuro-Oncol"},{"key":"5656_CR21","doi-asserted-by":"publisher","first-page":"iv84","DOI":"10.1093\/annonc\/mdx221","volume":"28","author":"E Le Rhun","year":"2017","unstructured":"Le Rhun E, Weller M, Brandsma D et al (2017) EANO\u2013ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours\u2020. Ann Oncol 28:iv84\u2013iv99. https:\/\/doi.org\/10.1093\/annonc\/mdx221","journal-title":"Ann Oncol"},{"issue":"8","key":"5656_CR22","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1016\/S1470-2045(23)00286-3","volume":"24","author":"D Pasquier","year":"2023","unstructured":"Pasquier D, Bidaut L, Oprea-Lager DE et al (2023) Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups. Lancet Oncol 24(8):e331\u2013e343. https:\/\/doi.org\/10.1016\/S1470-2045(23)00286-3","journal-title":"Lancet Oncol"},{"issue":"5","key":"5656_CR23","doi-asserted-by":"publisher","first-page":"103447","DOI":"10.1016\/j.esmoop.2024.103447","volume":"9","author":"N Epaillard","year":"2024","unstructured":"Epaillard N, Lusque A, Jacot W et al (2024) Incidence and outcome of brain and\/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort. ESMO Open 9(5):103447. https:\/\/doi.org\/10.1016\/j.esmoop.2024.103447","journal-title":"ESMO Open"},{"issue":"6","key":"5656_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nrclinonc.2011.58","volume":"8","author":"AF Eichler","year":"2011","unstructured":"Eichler AF, Chung E, Kodack DP, Loeffler JS, Fukumura D, Jain RK (2011) The biology of brain metastases-translation to new therapies. Nat Rev Clin Oncol 8(6):344\u2013356. https:\/\/doi.org\/10.1038\/nrclinonc.2011.58","journal-title":"Nat Rev Clin Oncol"},{"issue":"Suppl 5","key":"5656_CR25","doi-asserted-by":"publisher","first-page":"v121","DOI":"10.1093\/noajnl\/vdab121","volume":"3","author":"ES Srinivasan","year":"2021","unstructured":"Srinivasan ES, Deshpande K, Neman J, Winkler F, Khasraw M (2021) The microenvironment of brain metastases from solid tumors. Neuro-Oncol Adv 3(Suppl 5):v121\u2013v132. https:\/\/doi.org\/10.1093\/noajnl\/vdab121","journal-title":"Neuro-Oncol Adv"},{"issue":"5","key":"5656_CR26","doi-asserted-by":"publisher","first-page":"e207959","DOI":"10.1212\/WNL.0000000000207959","volume":"102","author":"E Le Rhun","year":"2024","unstructured":"Le Rhun E, Devos P, Seystahl K et al (2024) Prognostic Role of Ventricular Size and Its Dynamics in Patients With Leptomeningeal Metastasis From Solid Tumors. Neurology 102(5):e207959. https:\/\/doi.org\/10.1212\/WNL.0000000000207959","journal-title":"Neurology"},{"key":"5656_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.critrevonc.2019.01.020","volume":"135","author":"MA Franzoi","year":"2019","unstructured":"Franzoi MA, Hortobagyi GN (2019) Leptomeningeal carcinomatosis in patients with breast cancer. Crit Rev Oncol Hematol 135:85\u201394. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.01.020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7624","key":"5656_CR28","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"EV Elm","year":"2007","unstructured":"Elm EV, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2007) Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335(7624):806\u2013808. https:\/\/doi.org\/10.1136\/bmj.39335.541782.AD","journal-title":"BMJ"},{"key":"5656_CR29","doi-asserted-by":"publisher","unstructured":"Real-world experience outcome in patients with central nervous system metastases: information on 2,226 patients during a 15-year period. J Neurooncol. | Springer Nature Link. Accessed May 21 (2026) https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s11060-025-05190-y","DOI":"10.1007\/s11060-025-05190-y"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05656-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05656-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05656-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:39:19Z","timestamp":1782805159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05656-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5656"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05656-7","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki. Approval was granted by the Research Committees at the Instituto Nacional de Cancerolog\u00eda, Mexico City (CCI 2024\/024; March 31, 2024). Due to the retrospective nature of the study, the requirement for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}